Phio Pharmaceuticals Corp. Files 8-K
Ticker: PHIO · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 8-K |
| Filed Date | Jul 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing-update
Related Tickers: PHIO
TL;DR
Phio Pharma (PHIO) filed an 8-K on 7/7/25, updating office location and former name.
AI Summary
Phio Pharmaceuticals Corp. filed an 8-K on July 7, 2025, reporting "Other Events." The filing indicates the company's principal executive offices are located at 411 Swedeland Road, Suite 23-1080, King of Prussia, PA 19406. The company was formerly known as RXi Pharmaceuticals Corp. until October 19, 2011.
Why It Matters
This filing serves as an official notification of significant corporate events, providing transparency to investors about the company's operational status and history.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Registrant
- RXi Pharmaceuticals Corp (company) — Former company name
- July 7, 2025 (date) — Date of report
- King of Prussia, PA (location) — Location of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report "Other Events" as per Section 13 or 15(d) of the Securities Exchange Act of 1934.
When was this report filed?
This report was filed on July 7, 2025.
What is the current address of Phio Pharmaceuticals Corp.'s principal executive offices?
The principal executive offices are located at 411 Swedeland Road, Suite 23-1080, King of Prussia, PA 19406.
What was the company's former name?
The company's former name was RXi Pharmaceuticals Corp.
On what date did the company change its name from RXi Pharmaceuticals Corp.?
The date of the name change from RXi Pharmaceuticals Corp. was October 19, 2011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding Phio Pharmaceuticals Corp. (PHIO).